Medical Equipment

Sleep Disorder Market Growth Expected To Reach $65.5 Billion By 2030 At 14.4% CAGR

May 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Sleep Disorder Market During The Forecast Period?

The sleep disorder market has experienced substantial expansion in recent times. Projections indicate its expansion from $33.32 billion in 2025 to $38.23 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 14.7%. Historical growth factors include heightened awareness regarding sleep health, the increasing occurrence of insomnia and sleep apnea, greater uptake of sleep diagnostic services, an expanding older population, more stress and lifestyle-induced sleep problems, and the wider use of smartphones and wearable devices for tracking sleep patterns.

The sleep disorder market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach a valuation of $65.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.4%. This projected growth throughout the forecast period stems from factors such as the broader availability of telemedicine services for sleep conditions, increasing use of wearable devices for sleep tracking, a rise in diagnostic tests conducted at home, the development of cognitive behavioral therapy applications, and increased government efforts to raise awareness about sleep health. Key trends expected during this period involve advancements in wearable sleep monitoring technologies, enhancements in home-based sleep diagnostic equipment, progress in AI-powered sleep analysis, novel non-invasive treatments for sleep apnea, new approaches in telemedicine for sleep consultations, and innovative cognitive behavioral therapy applications.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30744&type=smp

Which Major Drivers Are Influencing The Expansion Of The Sleep Disorder Market?

The anticipated future expansion of the sleep disorder market is driven by increasing stress and anxiety levels. These levels denote the prevalence of psychological strain and excessive worry within a population, frequently arising from environmental, social, or economic pressures. The rise in stress and anxiety is attributed to work-related pressures, as employees contend with heavier workloads, stringent deadlines, and job insecurity. Such levels contribute to sleep disorders by disrupting normal sleep patterns and making it harder to fall or remain asleep. They also worsen overall health by impairing restorative sleep, leading to fatigue, cognitive decline, and an elevated risk of chronic conditions. For instance, in May 2024, the American Psychiatric Association (APA), a US-based professional association, reported that 43% of U.S. adults stated they felt more anxious in 2024 than the previous year, an increase from 37% in 2023 and 32% in 2022. Therefore, rising stress and anxiety levels are propelling the growth of the sleep disorder market.

What Are The Key Segment Divisions In The Sleep Disorder Market Segment Structure?

The sleep disorder market covered in this report is segmented –

1) By Disorder Type: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Circadian Rhythm Disorders

2) By Treatment: Cognitive Behavioral Therapy, Medication Therapy, Psychiatric Treatment, Behavioral Treatment

3) By Diagnostic Method: Polysomnography, Home Sleep Testing, Actigraphy, Sleep Diaries, Questionnaires and Screening

4) By Distribution Channel: Retail Pharmacies, Online Sales, Hospital Pharmacies

5) By End-User: Hospitals And Sleep Centers, Home Care Settings, Academic

Subsegments:

1) By Insomnia: Acute Insomnia, Chronic Insomnia, Onset Insomnia, Maintenance Insomnia, Behavioral Insomnia, Medication-Induced Insomnia

2) By Sleep Apnea: Obstructive Sleep Apnea, Central Sleep Apnea, Complex Sleep Apnea Syndrome, Mild Sleep Apnea, Moderate Sleep Apnea, Severe Sleep Apnea, Pediatric Sleep Apnea, Treatment-Resistant Sleep Apnea

3) By Restless Legs Syndrome: Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome, Mild Restless Legs Syndrome, Moderate Restless Legs Syndrome, Severe Restless Legs Syndrome, Intermittent Restless Legs Syndrome, Chronic Persistent Restless Legs Syndrome

4) By Narcolepsy: Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia, Pediatric Narcolepsy, Treatment-Resistant Narcolepsy, Secondary Narcolepsy

5) By Circadian Rhythm Disorders: Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Shift Work Sleep Disorder, Jet Lag Disorder, Irregular Sleep-Wake Rhythm Disorder, Non-24-Hour Sleep-Wake Disorder

Which Trends Are Shaping The Sleep Disorder Market?

Major companies operating in the sleep disorder market are concentrating on developing sophisticated therapeutic technologies, such as electrical vestibular nerve stimulation (VeNS) methods, to offer non-pharmacological treatment options that enhance sleep quality, regulate circadian rhythms, and support individuals with chronic insomnia. The electrical vestibular nerve stimulation (VeNS) method refers to a non-invasive therapeutic approach that delivers low-level electrical pulses to the vestibular nerve, a crucial neural pathway for influencing brain regions involved in sleep regulation without surgical intervention or pharmaceuticals. For instance, in October 2024, Neurovalens Ltd., a UK–based health-tech company, introduced Modius Sleep, an FDA-cleared non-invasive device engineered to treat chronic insomnia utilizing electrical vestibular nerve stimulation (VeNS). This headset-style medical device is worn for approximately 30 minutes each evening, sending safe electrical pulses to the vestibular nerve to impact the hypothalamus and brainstem areas that control circadian rhythm and sleep patterns, thereby helping users fall asleep faster and remain asleep longer.

Which Organizations Are Engaged In The Sleep Disorder Market?

Major companies operating in the sleep disorder market are Johnson & Johnson, Merck & Co. Inc., Pfizer Inc., Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Biogen Inc., Union Chimique Belge S.A., Sun Pharmaceutical Industries Ltd., Eisai Co. Ltd., Jazz Pharmaceuticals plc, Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Limited, H. Lundbeck A/S, Sumitomo Pharma Co. Ltd., Neurocrine Biosciences Inc., Harmony Biosciences Holdings Inc., Vanda Pharmaceuticals Inc.

Get The Full Sleep Disorder Market Report:

https://www.thebusinessresearchcompany.com/report/sleep-disorder-market-report

Which Geographic Region Dominates The Sleep Disorder Market?

North America was the largest region in the sleep disorder market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleep disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sleep Disorder Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30744&type=smp

Browse Through More Reports Similar to the Global Sleep Disorder Market 2026, By The Business Research Company

Insomnia Market Report 2026

https://www.thebusinessresearchcompany.com/report/insomnia-global-market-report

Sleeping Aids Market Report 2026

https://www.thebusinessresearchcompany.com/report/sleeping-aids-global-market-report

sleep testing services global market report

https://www.thebusinessresearchcompany.com/report/sleep-testing-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795